Catalent

Few oral biologics have made it to market, and though the challenges are well known, the benefits are huge and the task is not impossible. New technologies can help.

The pressure for increased efficiency pervades the pharma industry, including the clinical trials sector, where traditional supply models can lead to overstocking, waste and higher costs. Is there a more effective supply strategy?

Drug delivery by inhalation promises convenience and speed in many applications from the emergency room to home-based self-administration. But to succeed, the interactions between formulation, device and metering mechanism must be perfectly balanced with human factors. These challenges are a source of fascination for those looking to deliver drugs less invasively.

What if biologics and vaccines could be delivered via the buccal or sublingual route?

There are many hurdles in drug development, but your chances of success increase significantly if you pay more attention to API optimization from the outset.

Quality by Design: we’ve all heard the phrase – and know we should be fully on board with the philosophy. But how?

Alternative delivery routes for large-molecule drugs are sorely needed – could a new consortium lead the way?

What techniques will be in the toolbox 10 years from now? We speak to academic and industry experts to find out.

The days of “low-hanging fruit” in drug discovery are a thing of the past.

Catalent’s proven GPEx® platform creates stable, high-yielding mammalian cell lines, with high speed and efficiency

Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics in the US and Europe.

Catalent’s OneXpress™ solution combines phase-appropriate scale and technologies with expertise across diverse dose forms to accelerate drug programs

Catalent Xpress Pharmaceutics™ is an integrated development solution to facilitate adaptive clinical trials and accelerate oral drugs

Catalent helps its partners accelerate more than 1,000 programs and launch over 150 new products every year

Our solid state science expertise, under our PHARMORPHIX® brand, supports leading drug discovery and development

Catalent offers FlexDirect® direct-to-patient supply solutions, enabling clinical supplies to be sent directly to patients’ homes.

Catalent has more than 25 years’ experience as a global leader in clinical supply services

Catalent Cell & Gene Therapy is a full-service partner for a number of cell and gene technology platforms

Catalent’s OneXpress is a single integrated solution that provides the fastest pathway from clinical development to commercial manufacturing.